Revenue, 2025

USD 11.8 Billion

Forecast, 2035

USD 27.68 Billion

CAGR, 2026-2035

8.9%

Report Coverage

Global

Chromatography in the Biotechnology Market Trends for 2026

The global chromatography in the biotechnology market size was estimated at USD 11.8 billion in 2025 and is predicted to increase from USD 12.85 billion in 2026 to approximately USD 27.68 billion by 2035, expanding at a CAGR of 8.9% from 2026 to 2035.

The market is growing rapidly, driven by increasing demand for protein and antibody purification, advanced analytical techniques, and biopharmaceutical production. High-resolution, efficient, and scalable chromatography solutions are crucial for research, diagnostics, and industrial applications.

Key Takeaways

• Chromatography in the biotechnology market to crossed USD 12.85 billion by 2026.
• Market projected at USD 27.68 billion by 2035.
• CAGR of 8.9% expected in between 2026 to 2035.
• North America dominated the chromatography in the biotechnology market by 38% in 2025.
• Asia Pacific is expected to grow at the fastest CAGR in the market during the forecast period.
• By type/technique, the liquid chromatography (LC) segment holds a dominant position in the market by 38% in 2025.
• By type/technique, the gas chromatography (GC) segment is expected to grow at the fastest CAGR in the market during the forecast period.
• By product type/component, the chromatography instruments segment led the market by 46% in 2025.
• By product type/component, the chromatography consumables segment is expected to grow at the fastest CAGR in the market during the forecast period.
• By application, the drug discovery/pharmaceutical analysis segment dominated the market by 34% in 2025. 
• By application, the protein purification segment is expected to grow at the fastest CAGR in the market during the forecast period.
• By end-user, the pharmaceutical companies segment held the largest market share by 42% in 2025.
• By end-user, expected to grow at the fastest CAGR in the market during the forecast period.

Rising Demand Fuels Growth of Chromatology in Biotechnology

Chromatology in biotechnology is a technique to separate, identify, and purify biomolecules like proteins, DNA, and metabolites based on their physical or chemical properties for research, diagnostics, and pharmaceutical applications. The chromatography in the biotechnology market is expanding rapidly due to increasing demand for high-purity proteins, antibodies, and vaccines. Growing biopharmaceutical production, advancements in analytical and separation techniques, and stricter regulatory requirements for product quality are driving adoption. Additionally, rising research in genomics, proteomics, and diagnostics fuels the need for efficient, scalable, and precise chromatography solutions, making it an essential tool across laboratories, industrial processes, and pharmaceutical manufacturing.

Global Biopharma Production Gains Momentum

How Can AI Affect Chromatography in the Biotechnology Market?

Artificial intelligence (AI) is revolutionizing the market by enhancing data analysis, optimizing separation processes, and predicting experimental outcomes. AI-driven systems improve efficiency, reduce errors, and enable faster method development for protein purification, antibody production, and biomolecule analysis. By integrating machine learning with chromatography platforms, biotech companies can achieve higher precision, cost savings, and scalability, accelerating research, diagnostics, and biopharmaceutical manufacturing while driving innovation across the industry.

Trend and Future Outlook of Chromatography in the Biotechnology Market

• Integration of Advanced Technologies: Chromatography is increasingly combined with AI, automation, and high-throughput systems, improving efficiency, precision, and reproducibility in biomolecule separation, accelerating research, diagnostics, and biopharmaceutical production.
• Rising Biopharmaceutical Demand: The growing production of vaccines, antibodies, and therapeutic proteins is driving chromatography adoption, as high-purity, scalable, and reliable separation methods become essential in biotechnology manufacturing.
• Sustainable and Cost-Efficient Solutions: Future trends focus on eco-friendly resins, reusable columns, and energy-efficient systems, reducing operational costs while meeting stringent regulatory standards and sustainability goals in biotech laboratories and industries.

Quick Facts Table

Segmental Insights

By Type/Technique Insights

The Liquid Chromatography (LC) Segment Dominated the Market in 2025

Explanation

• Liquid Chromatography (LC) accounts for 38% of the market, leading due to its wide application in analytical and preparative processes across various industries.
• Gas Chromatography (GC) represents 18% of the market, commonly used for analyzing gases and volatile substances but with a smaller share compared to LC.
• Thin Layer Chromatography (TLC) holds 10% of the market, serving as a simpler and cost-effective method for qualitative analysis, though less commonly used than LC or GC.
• Supercritical Fluid Chromatography (SFC) accounts for 8% of the market, offering advanced capabilities for analyzing non-volatile and thermally labile compounds but with a smaller market share.
• Affinity Chromatography represents 12% of the market, widely used in biotechnological and pharmaceutical applications for separating biomolecules but still a smaller segment than LC.
• Ion Exchange Chromatography holds 9% of the market, used for separating charged particles in solutions, though it is less dominant compared to LC and GC.
• Others account for 5% of the market, covering various specialized chromatography techniques with a smaller share.

The liquid chromatography (LC) segment dominated the chromatography in the biotechnology market by 38% due to its high resolution, reproducibility, and speed. These techniques efficiently separate and analyze proteins, peptides, and nucleic acids, making them essential for biopharmaceutical production, quality control, and research applications. Their precision, scalability, and adaptability to complexity. Their precision, scalability, and adaptability to complex biomolecules drive widespread adoption across laboratories and industrial biotech processes.

The gas chromatography (GC) segment is expected to grow at the fastest CAGR due to its increasing use in analyzing volatile compounds, impurities, and residual solvents in biopharmaceuticals. Rising regulatory focus on product safety and quality drives its adoption in quality control and environmental monitoring. Additionally, advancements in detection technologies and their cost-effectiveness make gas chromatography a valuable tool in expanding biotechnology and pharmaceutical applications

By Product type/Component Insights

The Chromatography Instruments Segment Led the Market in 2025

Explanation

• Chromatography Instruments account for 46% of the market, dominating due to their essential role in performing various types of chromatographic analysis across industries.
• Chromatography Consumables represent 36% of the market, providing necessary materials for chromatography processes, though with a smaller share than instruments.
• Software & Services hold 18% of the market, supporting chromatographic processes with specialized software and analytical services, but they contribute less compared to instruments and consumables.

The chromatography instruments segment led the chromatography in the biotechnology market by 46% in 2025 due to their essential role in separation, detection, and analysis processes across biotechnology applications. High demand for advanced systems like HPLC and GC, increasing biopharmaceutical production, and the need for accurate, reproducible results drove adoption. Continuous technological advancements, automation, and integration with digital tools further strengthened their dominance in research quality control and industrial manufacturing.

The chromatography consumables segment is expected to grow at the fastest CAGR due to their repeated and continuous use in separation processes. Items such as columns, resins, solvents, and filters require frequent replacement, driving consistent demand. Increasing biopharmaceutical production, rising research activities, and the need for high-quality, reliable results further boost consumption. Additionally, advancements in specialized consumables enhanced efficiency and performance, supporting their rapid growth in biotechnology applications.

By Application Insights

The Drug Discovery/Pharmaceutical Analysis Segment held a Dominant Position in the Market

Explanation

• Drug Discovery / Pharmaceutical Analysis accounts for 34% of the market, leading due to its critical role in the development of new drugs and therapeutic treatments.
• Protein Purification represents 22% of the market, widely used in research and development to isolate proteins, though it holds a smaller share than drug discovery applications.
• Genetic Engineering holds 14% of the market, supporting genetic modification processes, but with a smaller share compared to drug discovery and protein purification.
• Cancer Research accounts for 16% of the market, driven by the ongoing need for advanced techniques in the fight against cancer, though still smaller than drug discovery.
• Pathology Testing represents 9% of the market, supporting medical diagnostics, though it holds a smaller share compared to more research-focused applications.
• Others make up 5% of the market, covering various specialized applications with a smaller market presence.

The drug discovery/pharmaceutical analysis segment held a dominant market share by 34% in 2025 due to the growing need for accurate identification, purification, and validation of drug compounds. Chromatography plays a critical role in analyzing complex molecules, ensuring safety, efficacy, and regulatory compliance. Increasing R&D investments, rising demand for novel therapeutics, and stringent quality standards further drive its adoption, making it essential in every stage of drug development and pharmaceutical testing processes.

The protein purification segment is expected to grow at the fastest CAGR due to increasing demand for biologics, monoclonal antibodies, and recombinant proteins. Chromatography plays a crucial role in achieving high purity and yield, essential for therapeutic applications. Rising investments in biopharmaceutical research, expanding clinical pipelines, and the need for efficient downstream processing further drive demand, making protein purification a key focus area in the biotechnology and pharmaceutical industries.

By End-User Insights

The Pharmaceutical Companies Segment held the Largest Market Share in 2025

Explanation

• Pharmaceutical Companies account for 42% of the market, leading due to their significant demand for research, development, and manufacturing of drugs and therapies.
• Biotechnology Companies represent 21% of the market, focusing on the development of biopharmaceuticals and genetic therapies, though they hold a smaller share compared to pharmaceutical companies.
• Academic & Research Institutions hold 16% of the market, playing a key role in scientific studies and innovations, but with a smaller share compared to industry-focused end-users.
• Hospitals & Diagnostic Labs account for 12% of the market, supporting clinical care and diagnostics, though they hold a smaller share in comparison to pharmaceutical and biotechnology companies.
• CROs make up 9% of the market, providing outsourced research and clinical trials services, but they represent the smallest share among the end-users.

Pharmaceutical companies held the largest market share in chromatography in the biotechnology market by 42% in 2025 due to their extensive use of chromatography in drug development, quality control, and regulatory compliance. High investment in research and development, increasing production of biologics and small-molecule drugs, and strict safety standards drive demand. Additionally, the need for precise separation and analysis of complex compounds makes chromatography essential, ensuring consistent product quality and supporting large-scale manufacturing operations.

The biotechnology companies segment is expected to grow at the fastest CAGR due to increasing focus on biologics, gene therapies, and personalized medicine. These companies rely heavily on chromatography for protein purification and biomolecule analysis. Rising investment, expanding research pipelines, and growing demand for innovative therapies drive adoption. Additionally, advancements in biotech processes and the need for high-precision separation technologies further accelerate chromatography usage in the rapidly evolving segment.

Regional Insights

North America Leads the Chromatography Revolution

North America dominated the global chromatography in the biotechnology market by 38% due to the strong presence of leading biopharmaceutical companies, advanced research infrastructure, and high R&D investments. The region benefits from early adoption of advanced technologies, well-established regulatory frameworks, and increasing demand for biologics and precision medicines. Additionally, continuous innovation, supporting government funding, and a robust healthcare system further drive the widespread use of chromatography across research, diagnostics, and pharmaceutical manufacturing.

U.S. Market Trends

The U.S. leads the chromatography in the biotechnology market due to its strong biopharmaceutical industry, high R&D spending, and advanced technological capabilities. The presence of major market players, well-established research institutions, and the rapid adoption of innovative separation techniques drive growth. Additionally, stringent regulatory standards and increasing demand for biologics and precision medicine further strengthen the country’s dominance in this market.

Asia Pacific: The Fastest-Rising Chromatography Hub

Asia Pacific is anticipated to grow at the fastest CAGR in chromatography in the biotechnology market due to expanding biopharmaceutical manufacturing, increasing investments in research and development, and rising demand for biologics. Rapid growth of biotechnology companies, improving healthcare infrastructure, and supportive government initiatives further boost adoption. Additionally, cost-effective manufacturing and a growing focus on advanced analytical technologies are accelerating the use of chromatography across the region.

India Market Trends

India is anticipated to grow at the fastest CAGR in the chromatography in the biotechnology market due to rising biopharmaceutical production, increasing investments in research and development, and a rapidly expanding biotechnology sector. Government support, improving healthcare infrastructure, and growing demand for affordable biologics further drive market growth. Additionally, the presence of skilled professionals and cost-effective manufacturing capabilities accelerates the adoption of advanced chromatography techniques across research and industrial applications.

Europe: Steady Growth Driven by Innovation and Regulation

Europe is anticipated to grow at a notable CAGR in chromatography in the biotechnology market due to strong research capabilities, increasing biopharmaceutical production, and strict regulatory standards ensuring product quality. Rising investments in life science, the presence of established pharmaceutical companies, and a growing focus on advanced analytical technologies further support market expansion across research, diagnostics, and manufacturing applications.

UK Market Trends

The UK is expected to grow at a significant rate in chromatography in the biotechnology market due to strong academic research, increasing biopharmaceutical development, and government support for life sciences. Rising investments in advanced analytical technologies and a growing focus on precision medicine further drive demand. Additionally, the presence of leading research institutions and collaborations between industry and academia enhances innovation and adoption of chromatography solutions.

Supply Chain Analysis

R&D

• Research and development in chromatography for biotechnology is centered on improving separation efficiency, accuracy, and processing speed, especially for complex biologics such as monoclonal antibodies, mRNA-based products, and cell therapies. Continuous innovation aims to enhance productivity and scalability in bioprocessing.
• Key Players: Thermo Fisher Scientific, Cytiva, Agilent Technologies, and Merck KGaA.

Clinical Trials

• Chromatography plays a crucial role in biotechnology clinical trials by enabling the purification of biopharmaceuticals, studying drug behavior in the body (ADME), and assessing bioactivity in complex biological samples. It supports accurate analysis and reliable results throughout drug development.
• Key players: Waters Corporation, Shimadzu Corporation, PerkinElmer, and Bio-Rad Laboratories.

Regulatory Approvals

• Regulatory approval of chromatography in biotechnology focuses on maintaining product safety, purity, and effectiveness. Techniques like HPLC, UHPLC, and affinity chromatography must be properly validated to meet global regulatory and GMP requirements, ensuring consistent removal of impurities in biologics. Compliance with international guidelines is critical throughout development and manufacturing.
• Key players: Danaher Corporation, GE Healthcare, Sartorius AG, and Restek Corporation.

Top Vendors in Chromatography in the Biotechnology Market & Their Offerings

SWOT Analysis

Strengths

• High precision and reliability in separating complex biomolecules.
• Essential for biopharmaceutical production and quality control.
• Wide applicability across research, diagnostics, and manufacturing.
• Scalable techniques suitable for both lab and industrial use.

Weaknesses

• High cost of instruments and consumables.
• Requires skilled professionals for operation and method development.
• Time-consuming processes for certain complex separations.
• Maintenance and validation can be resource-intensive.

Opportunities

• Growing demand for biologics, vaccines, and personalized medicine.
• Advancements in automation and AI-driven chromatography systems.
• Expansion of biotechnology research and emerging markets.
• Development of eco-friendly and cost-effective consumables.

Threats

• Availability of alternative separation technologies.
• Strict regulatory requirements are increasing the compliance burden.
• High initial investment limits adoption in smaller labs.
• Supply chain disruptions are affecting consumable availability.

What are the Recent Developments in Chromatography in the Biotechnology Market?

• In June 2025, advanced LC-MS integrated chromatography platforms improved sensitivity for complex biomolecule detection.
• In December 2024, laboratories adopted automated and digital chromatography workflows to increase accuracy and efficiency. 

Segments Covered in the Report

By Type/Technique

• Liquid Chromatography (LC)
• Gas Chromatography (GC)
• Thin Layer Chromatography (TLC)
• Supercritical Fluid Chromatography (SFC)
• Affinity Chromatography
• Ion Exchange Chromatography
• Others

By Product Type/Component

• Chromatography Instruments
• Chromatography Consumables (columns, reagents, resins, etc.)
• Software & Services

By Application

• Protein Purification
• Drug Discovery/Pharmaceutical Analysis
• Genetic Engineering
• Cancer Research
• Pathology Testing
• Others

By End-User

• Pharmaceutical Companies
• Biotechnology Companies
• Academic & Research Institutions
• Hospitals & Diagnostic Labs
• CROs (Contract Research Organizations)

By Region

• North America
  • U.S.
  • Canada 
  • Mexico 
  • Rest of North America
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America
• Europe 
  • Western Europe 
    • Germany 
    • Italy
    • France
    • Netherlands
    • Spain
    • Portugal 
    • Belgium
    • Ireland
    • UK 
    • Iceland 
    • Switzerland
    • Poland
    • Rest of Western Europe
  • Eastern Europe 
    • Austria
    • Russia & Belarus 
    • Türkiye
    • Albania 
    • Rest of Eastern Europe 
• Asia Pacific
  • China 
  • Taiwan
  • India 
  • Japan 
  • Australia and New Zealand
  • ASEAN Countries (Singapore, Malaysia)
  • South Korea 
  • Rest of APAC 
• MEA 
  • GCC Countries
    • Saudi Arabia 
    • United Arab Emirates (UAE)
    • Qatar 
    • Kuwait 
    • Oman 
    • Bahrain 
  • South Africa
  • Egypt 
  • Rest of MEA